/DMIIR
DMIIR Stock - Drugs Made In America Acquisition II Corp. Right
Financial Services|Asset ManagementNASDAQ
$0.12+3.25%
+$0.00 (+3.25%) • Dec 19
54
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.15
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.14
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for DMIIR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.12 – $0.13
TARGET (TP)$0.14
STOP LOSS$0.11
RISK/REWARD1:1.2
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.00
52W High$0.12
52W Low$0.12
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 |
|---|---|
| Revenue | N/A |
| Gross Profit | N/A |
| Gross Margin | N/A |
| Operating Income | $-151,719 |
| Net Income | $-151,719 |
| Net Margin | N/A |
| EPS | $-0.00 |
Company Overview
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Loading analyst ratings...
Earnings History & Surprises
DMIIRLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about DMIIR
What is DMIIR's current stock price?
Drugs Made In America Acquisition II Corp. Right (DMIIR) is currently trading at $0.12 per share. The stock has moved +3.25% today.
What is the analyst price target for DMIIR?
No analyst price targets are currently available for this stock.
What sector is Drugs Made In America Acquisition II Corp. Right in?
Drugs Made In America Acquisition II Corp. Right operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the NASDAQ exchange.
What is DMIIR's market cap?
Drugs Made In America Acquisition II Corp. Right has a market capitalization of $0.01 billion, making it a small-cap company.
Does DMIIR pay dividends?
No, Drugs Made In America Acquisition II Corp. Right does not currently pay a dividend to shareholders.